ZL-59

N/A

Report date: 2025/04/30 14:07:25
NME

Base Information

Drug NameZL-59
Drug Alias NameZL-59ZL59
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSystemic Inflammatory Response SyndromeInflammationGraft vs Host Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesChengdu Zenitar Biomedical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengdu Zenitar Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSystemic Inflammatory Response SyndromeInflammationGraft vs Host Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A